This collection is a collaboration between Frontiers in Drug Delivery and Frontiers’ flagship journal, Frontiers for Young Minds, an award‑winning, ...

Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population. Methotrexate (MTX) reduces cardiovascular risk in patients with rheumatoid arthritis ...

Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...

An investigation initiated from a bachelor's thesis at the Autonomous University of Barcelona, with the participation of researchers from the Neurosciences Institute of the UAB (INc-UAB), the ...